Reaction
Atrial Thrombosis reporting signals
As of the last recalculation, Atrial Thrombosis appears in 2,052 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE (PRR 52.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabigatran Etexilate | 337 | 52.5 | 52.7 |
| Dabigatran Etexilate Mesylate | 311 | 51.0 | 51.2 |
| Rivaroxaban | 481 | 30.3 | 30.4 |
| Eplerenone | 33 | 26.6 | 26.6 |
| Sotalol Hydrochloride | 27 | 16.7 | 16.7 |
| Heparin Sodium | 21 | 15.6 | 15.7 |
| Apixaban | 88 | 13.9 | 13.9 |
| Pegaspargase | 14 | 11.7 | 11.7 |
| Tafamidis | 12 | 10.4 | 10.4 |
| Tranexamic Acid | 9 | 10.3 | 10.3 |
| Torsemide | 31 | 9.6 | 9.6 |
| Warfarin | 105 | 8.8 | 8.8 |
| Digoxin | 58 | 8.4 | 8.4 |
| Mercaptopurine | 14 | 8.2 | 8.2 |
| Bisoprolol Fumarate | 103 | 8.0 | 8.0 |
| Bleomycin Sulfate | 8 | 7.9 | 7.9 |
| Gentamicin | 10 | 7.8 | 7.8 |
| Alteplase | 11 | 7.5 | 7.5 |
| Thiotepa | 6 | 6.4 | 6.4 |
| Clopidogrel Bisulfate | 61 | 6.2 | 6.2 |
| Pertuzumab | 16 | 6.0 | 6.0 |
| Febuxostat Tablets 40 Mg | 6 | 6.0 | 6.0 |
| Febuxostat Tablets 80 Mg | 6 | 6.0 | 6.0 |
| Romiplostim | 8 | 5.4 | 5.4 |
| Eltrombopag Olamine | 12 | 5.3 | 5.3 |
| Dronedarone | 5 | 5.0 | 5.0 |
| Tolvaptan | 7 | 4.9 | 4.9 |
| Trastuzumab | 31 | 4.6 | 4.6 |
| Emicizumab | 5 | 4.1 | 4.1 |
| Prasugrel Hydrochloride | 4 | 4.0 | 4.0 |
| Blinatumomab | 4 | 3.9 | 3.9 |
| Gemcitabine | 15 | 3.9 | 3.9 |
| Dofetilide | 4 | 3.9 | 3.9 |
| Gefitinib | 3 | 3.4 | 3.4 |
| Drospirenone And Ethinyl Estradiol | 13 | 3.0 | 3.0 |